Search results for "illness"

showing 10 items of 1529 documents

Phenprocoumon-induced liver disease ranges from mild acute hepatitis to (sub-) acute liver failure

2003

Abstract Background/Aims Except for bleeding complications, other serious adverse reactions of coumarin anticoagulants such as hepatotoxicity or skin necrosis are comparatively rare. Nonetheless, a small number of coumarin-induced (sub-) acute liver failures has been published. Methods A retrospective analysis was performed of patients treated for liver disease between 1992 and 2002 at our department to evaluate the incidence, clinical findings and histopathology of coumarin-induced hepatotoxicity. Results The retrospective analysis revealed eight cases of phenprocoumon-induced hepatotoxicity, including three cases of (sub-) acute liver failure which resulted in two orthotopic liver transpl…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentLiver transplantationSeverity of Illness IndexGastroenterologyPhenprocoumonLiver diseaseGermanyInternal medicinemedicineHumansAdverse effectRetrospective StudiesHepatitisLiver injuryHepatologybusiness.industryLiver cellAnticoagulantsLiver Failure AcuteMiddle Agedmedicine.diseaseSurgeryAcute DiseasePhenprocoumonFemaleChemical and Drug Induced Liver InjuryComplicationbusinessmedicine.drugJournal of Hepatology
researchProduct

Cognitive behavioral therapy for chronic insomnia inoccupationalhealth services: Analyses of outcomes upto24monthspost-treatment

2013

Abstract Objective Cognitive behavioral therapy for insomnia (CBT-I) is an effective treatment for persistent insomnia. The purpose of this study was to examine the effectiveness of and response patterns to CBT-I among daytime and shift workers with insomnia over a 24-month follow-up in occupational health services (OHS). Methods The participants were 59 media workers with chronic insomnia, of whom 69% were reached at 24-month follow-up. Sleep diaries and questionnaires over seven measurement points were used as outcomes. Trained OHS nurses led the CBT-I groups. The study design was a non-randomized group intervention. Results Self-perceived severity of insomnia, sleep-related dysfunctional…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentOccupational Health ServicesExperimental and Cognitive PsychologyDysfunctional familyCognitive behavioral therapy for insomniaAffect (psychology)Severity of Illness IndexOccupational safety and healthMedical RecordsShift workSleep Disorders Circadian RhythmSleep Initiation and Maintenance DisordersSurveys and Questionnairesmental disordersmedicineInsomniaHumansCognitive Behavioral TherapyCognitionta3141Middle Aged3. Good healthCognitive behavioral therapyPsychiatry and Mental healthClinical PsychologyPhysical therapyFemalemedicine.symptomPsychologyClinical psychologyFollow-Up StudiesBehaviour Research and Therapy
researchProduct

Life goals after brain injury in the light of the dual process approach: empirical evidence and implications for neuropsychological rehabilitation.

2011

Sequelae of acquired brain injury endanger the realisation of important life-goals. Discrepancies arise between the importance attached to a goal and the success in realising it. This study investigates goal discrepancies and their influence on patients' subjective well-being (SWB) in different rehabilitation stages. Life-goals, SWB and daily functioning were assessed in 130 neurological inpatients and 42 outpatients by self-report questionnaires. Both patient groups reported greater discrepancies between importance and success of life-goals than a normative sample of healthy controls. In multiple regression modelling, goal discrepancy predicted SWB in the inpatient sample even when control…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentPoison controlPersonal SatisfactionSeverity of Illness IndexOccupational safety and healthArts and Humanities (miscellaneous)Injury preventionActivities of Daily LivingmedicineHumansSubjective well-beingPsychiatryAcquired brain injuryApplied PsychologyPsychiatric Status Rating ScalesRehabilitationRehabilitationNeuropsychologyHuman factors and ergonomicsMiddle Agedmedicine.diseaseNeuropsychology and Physiological PsychologyBrain InjuriesCase-Control StudiesFemaleSelf ReportPsychologyGoalsClinical psychologyNeuropsychological rehabilitation
researchProduct

Fluoroquinolone-induced liver injury: three new cases and a review of the literature.

2012

PURPOSE: Fluoroquinolones are popular and widely used in primary care and hospital settings. Premarketing studies showed a favourable side-effect profile. However, significant morbidity and the need for liver transplantation for acute liver failure have been reported. We reviewed the available data on liver damage linked to fluoroquinolones. METHODS: A systematic search of case reports on the MEDLINE database encompassing the years 2000-2011 was carried out. Additional references were found by a manual search of the retrieved paper. We also describe three new cases of hepatotoxicity attributable to fluoroquinolones seen at our Unit. RESULTS: Thirty-five cases were retrieved from MEDLINE (51…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentTreatment outcomePrimary careLiver transplantationfluoroquinoloneSeverity of Illness IndexSeverity of illnessMedicineHumansPharmacology (medical)Liver damageIntensive care medicinePharmacologyHepatitisLiver injurySettore MED/12 - Gastroenterologiabusiness.industryLiver failureGeneral MedicineMiddle Agedmedicine.diseaseAnti-Bacterial AgentsTreatment OutcomeItalyliver damageSettore BIO/14 - FarmacologiaFemaleDILIChemical and Drug Induced Liver InjurybusinessFluoroquinolones
researchProduct

Vitamin D serum levels in multiorgan failure critically ill patients undergoing continuous renal replacement therapies

2020

Introduction Severe vitamin D deficiency in critically ill patients is linked to mortality. There are no scientific data regarding vitamin D status in critically ill patients undergoing continuous renal replacement therapies. Material and methods We aimed to measure vitamin D serum levels in critically ill patients with multi-organ failure undergoing continuous renal replacement therapies. Vitamin D serum measurements in 12-hour time intervals were performed in 20 patients undergoing continuous renal replacement therapies through continuous veno-venous haemodiafiltration (the study group). The results were then compared with the historical control group (20 patients without renal replacemen…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentcontinuous renal replacement therapyvitamin DCritical Care and Intensive Care MedicineSeverity of Illness IndexGastroenterologyvitamin D deficiencyAnesthesiologyInternal medicineIntensive caremedicineVitamin D and neurologyHumanscritical illnessRD78.3-87.3Renal replacement therapycritical illness.intensive careRC86-88.9Critically illbusiness.industryAcute kidney injuryMedical emergencies. Critical care. Intensive care. First aidGeneral MedicineMiddle AgedVitamin D Deficiencymedicine.diseaseMultiorgan failureAnesthesiology and Pain Medicineacute kidney injuryCase-Control StudiesCritical illnessbusinessAnaesthesiology Intensive Therapy
researchProduct

Severe herpes simplex virus type-I infections after dental procedures

2010

Background: Recurrences of herpes labialis (RHL) may be triggered by systemic factors, including stress, menses, and fever. Local stimuli, such as lip injury or sunlight exposure are also associated to RHL. Dental extraction has also been reported as triggering event. Case reports: Seven otherwise healthy patients are presented with severe and extensive RHL occurring about 2-3 days after dental extraction under local anaesthesia. Immunohistochemistry on smears and immunofluorescence on cell culture identified herpes simplex virus type I (HSV-I). Five patients reported more severe prodromal signs than usual. Although all the patients suffered from RHL, none had previously experienced RHL aft…

AdultMalemedicine.medical_specialtymedicine.medical_treatmentmedicine.disease_causeSeverity of Illness IndexYoung AdultSeverity of illnessHumansMedicineYoung adultGeneral DentistryHerpes Labialisbusiness.industryIncidence (epidemiology)Herpes SimplexMiddle Aged:CIENCIAS MÉDICAS [UNESCO]DermatologySurgeryValaciclovirHerpes simplex virusOtorhinolaryngologyDental extractionTooth ExtractionUNESCO::CIENCIAS MÉDICASFemaleSurgerybusinessComplicationmedicine.drug
researchProduct

Personalized Goal for Dyspnea and Clinical Response in Advanced Cancer Patients

2018

Abstract Background The clinical response after comprehensive symptom management is difficult to determine in terms of a clinically important difference. Moreover, therapies should try to reach the threshold perceived by the individual patient for the determination of a favorable response to a treatment. Measures The Edmonton Symptom Assessment Score (ESAS) was measured at admission (T0), and seven days after starting palliative care (T7). Patient Global Impression and Goal Response after one week of palliative care and its relation with the Personalized Dyspnea Goal were measured at T7. Intervention Patients admitted to palliative care units underwent a comprehensive symptom assessment by …

AdultMalemedicine.medical_specialtypersonalized symptom goalPalliative careDecision MakingSymptom assessmentSeverity of Illness Index03 medical and health sciences0302 clinical medicineNeoplasmsAdvanced cancerHumansMedicine030212 general & internal medicinePrecision MedicineGeneral NursingSpecialist palliative careglobal impression of changeNursing (all)2901 Nursing (miscellaneous)AgedAged 80 and oversymptom assessmentpalliative carebusiness.industrySymptom managementMinimal clinically important differenceDisease ManagementMiddle AgeddyspneaAnticipation PsychologicalAdvanced cancerrespiratory tract diseasesIntensity (physics)Treatment OutcomeAnesthesiology and Pain Medicine030220 oncology & carcinogenesisPhysical therapyDeliriumFemaleNeurology (clinical)medicine.symptombusiness
researchProduct

Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemia

2021

In β-thalassaemia, the severity of inherited β-globin gene mutations determines the severity of the clinical phenotype at presentation and subsequent transfusion requirements. However, data on associated long-term outcomes remain limited. We analysed data from 2109 β-thalassaemia patients with available genotypes in a global database. Genotype severity was grouped as β0 /β0 , β0 /β+ , β+ /β+ , β0 /β++ , β+ /β++ , and β++ /β++ . Patients were followed from birth until death or loss to follow-up. The median follow-up time was 34·1 years. Mortality and multiple morbidity outcomes were analyzed through five different stratification models of genotype severity groups. Interestingly, β0 and β+ mu…

AdultMalemedicine.medical_specialtyphenotypegenotypemorbidityKaplan-Meier Estimatebeta-GlobinsGene mutationβ thalassaemiaGlobal HealthGastroenterologySeverity of Illness IndexsurvivalCohort StudiesYoung AdultInternal medicineGenotypemedicineLong term outcomesOdds RatioHumansAllelesgenotype; morbidity; mortality; phenotype; survivalProportional Hazards Modelsbusiness.industrybeta-ThalassemiaDisease ManagementHematologyPrognosisPhenotypemortalityConfidence intervalPopulation SurveillanceCohortMutationFemaleRisk of deathbusinessFollow-Up Studies
researchProduct

Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelof…

2010

The International Prognostic Scoring System (IPSS) and karyotype are useful tools for risk stratification in primary myelofibrosis (PMF). We examined the additional prognostic impact of red blood cell transfusion need among 254 consecutive patients (median age, 59 years). Sixty-two patients ( approximately 24%) required transfusions at diagnosis whereas 22 ( approximately 9%) became transfusion-dependent and 170 remained transfusion-independent during the first year postdiagnosis; after a median follow-up of 55 months, the respective median survivals were 35, 25, and 117 months (P < 0.01). Multivariable analysis confirmed the IPSS- and karyotype-independent prognostic weight of transfusion …

AdultMalemedicine.medical_specialtytransfusion myelofibrosisPROGNOSISmedicine.medical_treatmentmyelofibrosisHematopoietic stem cell transplantationSeverity of Illness IndexSettore MED/15 - Malattie Del SangueRisk FactorsInternal medicineSeverity of illnessmedicineHumansMyelofibrosisSurvival analysisAgedRetrospective StudiesAged 80 and overChromosome AberrationsHematologybusiness.industryPatient SelectionMyelodysplastic syndromesHematopoietic Stem Cell TransplantationRetrospective cohort studyHematologyMiddle Agedmedicine.diseaseSurvival AnalysisSurgeryPrimary MyelofibrosisInternational Prognostic Scoring SystemRBC transfusiion; myelofibrosis; PROGNOSISFemaleErythrocyte TransfusionbusinessFollow-Up StudiesRBC transfusiionAmerican Journal of Hematology
researchProduct

Serum levels of interleukin-18 and s-ICAM-1 in patients affected by psoriasis: preliminary considerations.

2003

Objective To find new aspects of the systemic involvement of the Immune System in psoriasis, we determined serum levels of interleukin-18 (IL-18) (Th1-inducing factor cytokine), CD30 (Th2 marker) and sICAM-1 (adhesion molecule). In addition we evaluated the correlation between these molecules and psoriasis area and severity index (PASI). Background Psoriasis is associated to an overexpression of Th1 cytokines and a relative underexpression of Th2 cytokines. IL-18 plays an important role in inducing Th1 response because it is a potent inductor of synthesis of IFN-γ, TNF and other mediators. The two major sources of IL-18 are monocytes and macrophages but also human keratinocytes constitutive…

AdultMalemedicine.medical_treatmentKi-1 AntigenDermatologySeverity of Illness IndexImmune systemPsoriasis Area and Severity IndexPsoriasisMedicineHumansPsoriasisICAM-1business.industryCase-control studyInterleukin-18medicine.diseaseIntercellular Adhesion Molecule-1Infectious DiseasesCytokineCase-Control StudiesImmunologyInterleukin 18Tumor necrosis factor alphaFemalebusinessJournal of the European Academy of Dermatology and Venereology : JEADV
researchProduct